Literature DB >> 7461142

Antioxidant effects on the prostaglandin endoperoxide synthetase product profile.

M P Carpenter.   

Abstract

Lipid peroxides are produced during the enzymatic conversion of arachidonic acid to prostaglandins, thromboxane, prostacyclin, and leukotrienes. These peroxides include hydroperoxides of arachidonic acid formed by lipoxygenase and the prostaglandin endoperoxide intermediates produced by action of prostaglandin endoperoxide synthetase. A number of steps in the arachidonate-dependent prostaglandin pathway are vulnerable to antioxidant affects. Such points in the biosynthetic sequence include prostaglandin endoperoxide synthetase, both the cyclooxygenase and peroxidase activity, prostacyclin synthetase, thromboxane synthetase, and lipooxygenase. Antioxidants added in vitro have been shown to affect prostaglandin synthesis. The present review will stress the limited information concerning the in vivo effect of antioxidants. Studies carried out in the investigator's laboratory on prostaglandin synthesis have utilized rats deficient or replete in vitamin E or propyl gallate (an antioxidant). Differentiation of germ cells in the testis of the male rat is arrested in vitamin E deficiency. Testis microsomal prostaglandin synthesis is altered prior to any overt morphological change. The effect of exogenous antioxidant in either rat testis or mammary gland preparation depends both on the type of antioxidant and the concentration. However, the effects of in vivo and in vitro antioxidant on arachidonate turnover are not identical. The physiological effect of antioxidants on prostaglandin synthesis appear to be specific.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7461142

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  7 in total

1.  Effect of the ultrashort-acting beta-blocker Brevibloc on free-radical-mediated injuries during the early reperfusion state.

Authors:  E Röth; B Török
Journal:  Basic Res Cardiol       Date:  1991 Sep-Oct       Impact factor: 17.165

2.  Antioxidation theory of non-steroidal anti-inflammatory drugs based upon the inhibition of luminol-enhanced chemiluminescence from the myeloperoxidase reaction.

Authors:  G Pekoe; K Van Dyke; D Peden; H Mengoli; D English
Journal:  Agents Actions       Date:  1982-07

3.  Abnormal antioxidant defence in some tissues of congenitally obese mice.

Authors:  I D Capel; H M Dorrell
Journal:  Biochem J       Date:  1984-04-01       Impact factor: 3.857

4.  Effects of antioxidant therapy in experimentally induced heart infarcts.

Authors:  B Török; E Röth; V Bär; Z Pollák
Journal:  Basic Res Cardiol       Date:  1986 Mar-Apr       Impact factor: 17.165

5.  Comparison of the effects of antioxidant non-steroidal anti-inflammatory drugs against myeloperoxidase and hypochlorous acid luminol-enhanced chemiluminescence.

Authors:  G Pekoe; K Van Dyke; H Mengoli; D Peden; D English
Journal:  Agents Actions       Date:  1982-04

6.  Regulation of vascular prostaglandin synthesis by metabolites of arachidonic acid in perfused rabbit aorta.

Authors:  R S Kent; S L Diedrich; A R Whorton
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

7.  Mechanism of action of 5-arninosalicylic acid.

Authors:  N A Punchard; S M Greenfield; R P Thompson
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.